Global hygiene and health company Essity strengthens regional healthcare partnerships to build on Saudi Arabia's Vision 2030 transformation agenda Under Vision 2030, Saudi Arabia plans to invest over US$65 billion to develop the country's healthcare infrastructure. Establishing the regional headquarters for its Health & Medical business in Riyadh reflects Essity's commitment to long term growth in the Middle East, as the company taps on Saudi Arabia's Vision 2030 ambitions to shape the future of healthcare in this strategic market. Essity also signs a Memorandum of Understanding with leading Saudi healthcare distributors - Tamer Group and DMSCO - to collaborate on elevating healthcare standards and strengthening access to high quality health and medical solutions. 'Saudi Arabia is a strategic market to accelerate growth of Essity's health and medical business in the Middle East,' says Anand Chandarana, President of Business Unit Health & Medical for Essity. 'As a global leader in hygiene and health, we are well positioned to support Saudi Arabia's healthcare transformation, and deliver sustainable value to patients, customers and healthcare systems through our trusted brands and superior innovations.' Essity sells health and medical solutions under the TENA®, Cutimed®, Leukoplast®, Delta-Cast®, Actimove® and JOBST® brands in the Middle East.
| 
RSS Feed 
